Acutaas Chemicals Ltd.

₹2561

+ 60.50 (2.42%)

04:01 pm - close price

BSE: ACUTAAS

NSE: ACUTAAS

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 19.39Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.69Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 20.14Good: 20

✅

Current Ratio

Bad: 1Current: 3.91Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 16.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.53Good: 0.5

🟡

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 19.39Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.69Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 20.14Good: 20

✅

Current Ratio

Bad: 1Current: 3.91Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 16.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.53Good: 0.5

🟡

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	153.72	172.36	166.44	224.96	176.67
Expenditure+	119.71	147.54	139.93	181.80	147.15
Other Income+	1.15	1.50	3.49	1.34	1.04
Operating Profit	34.01	24.82	26.51	43.16	29.52
Interest	0.51	0.82	2.54	2.07	4.43
Depreciation and Amortization	3.71	3.69	3.76	4.90	6.18
Profit Before Tax	30.94	-9.94	23.70	37.20	19.96
Tax+	8.70	7.08	5.89	11.53	5.26
Net Profit	22.24	-17.02	17.81	25.68	14.69

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	34060.79	52013.50	61673.45	71747.45	100687.55
Operational Expenses+	26045.49	41495.94	49412.78	58898.47	77480.21
Operating Profit	8015.30	10517.56	12260.67	12848.98	23207.34
Other Income	137.97	276.23	431.98	749.09	1692.94
OPM %	23.53	20.22	19.88	17.91	23.05
Depreciation and Amortisation	418.81	1008.02	1234.24	1605.52	2662.14
Interest	561.84	640.73	241.23	594.03	621.84
Profit Before Tax	7172.62	9145.04	11217.18	8190.13	21616.30
Tax	1756.19	1950.43	2888.21	3319.33	5574.53
Net Profit	5399.89	7194.61	8328.97	4277.30	15871.36

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	41326.83	65888.29	76693.84	109590.33	154926.11
Liabilities+	41326.83	65888.29	76693.84	109590.33	154926.11

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	2796.04	-1193.48	6553.00	12516.97	11834.27
Cash from Investing Activity	-10120.51	-12071.57	-3304.40	-36539.35	-22394.32
Cash from Financing Activity	7210.83	14026.25	-1225.00	23936.36	26112.04
Net Cash Flow	-113.64	761.20	2023.60	-86.02	15551.99
Opening Cash & Cash Equivalents	382.16	268.46	1029.66	3053.26	2970.44
Closing Cash & Cash Equivalents	268.46	1029.66	3053.26	2970.44	18522.43

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	32.66	32.66	32.66	32.66	35.96	35.96	35.97	35.98	39.91	39.91
Public+	67.34	67.34	67.34	67.34	64.04	64.04	64.03	64.02	60.09	60.09
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	112939	110363	108664	119890	114060	95756	93394	90987	95784	83344

Corporate Actions

215 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	2796.04	-1193.48	6553.00	12516.97	11834.27
Cash from Investing Activity	-10120.51	-12071.57	-3304.40	-36539.35	-22394.32
Cash from Financing Activity	7210.83	14026.25	-1225.00	23936.36	26112.04
Net Cash Flow	-113.64	761.20	2023.60	-86.02	15551.99
Opening Cash & Cash Equivalents	382.16	268.46	1029.66	3053.26	2970.44
Closing Cash & Cash Equivalents	268.46	1029.66	3053.26	2970.44	18522.43

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	34060.79	52013.50	61673.45	71747.45	100687.55
Operational Expenses+	26045.49	41495.94	49412.78	58898.47	77480.21
Operating Profit	8015.30	10517.56	12260.67	12848.98	23207.34
Other Income	137.97	276.23	431.98	749.09	1692.94
OPM %	23.53	20.22	19.88	17.91	23.05
Depreciation and Amortisation	418.81	1008.02	1234.24	1605.52	2662.14
Interest	561.84	640.73	241.23	594.03	621.84
Profit Before Tax	7172.62	9145.04	11217.18	8190.13	21616.30
Tax	1756.19	1950.43	2888.21	3319.33	5574.53
Net Profit	5399.89	7194.61	8328.97	4277.30	15871.36

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	153.72	172.36	166.44	224.96	176.67
Expenditure+	119.71	147.54	139.93	181.80	147.15
Other Income+	1.15	1.50	3.49	1.34	1.04
Operating Profit	34.01	24.82	26.51	43.16	29.52
Interest	0.51	0.82	2.54	2.07	4.43
Depreciation and Amortization	3.71	3.69	3.76	4.90	6.18
Profit Before Tax	30.94	-9.94	23.70	37.20	19.96
Tax+	8.70	7.08	5.89	11.53	5.26
Net Profit	22.24	-17.02	17.81	25.68	14.69

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	41326.83	65888.29	76693.84	109590.33	154926.11
Liabilities+	41326.83	65888.29	76693.84	109590.33	154926.11

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	32.66	32.66	32.66	32.66	35.96	35.96	35.97	35.98	39.91	39.91
Public+	67.34	67.34	67.34	67.34	64.04	64.04	64.03	64.02	60.09	60.09
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	112939	110363	108664	119890	114060	95756	93394	90987	95784	83344

Ratios

Reported EPS

Bad: 2Current: 19.39Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.69Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 20.14Good: 20

✅

Current Ratio

Bad: 1Current: 3.91Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 16.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.53Good: 0.5

🟡

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 19.39Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.69Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 20.14Good: 20

✅

Current Ratio

Bad: 1Current: 3.91Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 16.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.53Good: 0.5

🟡

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Corporate Actions

215 events in the last 3 years

Acutaas Chemicals Ltd.

₹2561

+ 60.50 (2.42%)

04:01 pm - close price

BSE: ACUTAAS

NSE: ACUTAAS

Industry: Pharmaceuticals & Drugs

House: Private

Overview